MedPath

Bimatoprost 0,3mg/ml- Eyedrops for lash-lenghtening - Pilot Study

Conditions
women with too short lashes
Therapeutic area: Not possible to specify
Registration Number
EUCTR2014-002553-19-AT
Lead Sponsor
Medizinische Universität Graz, Universitätsklinik für Dermatologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

men and women from 16 to 99 years
infomed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5

Exclusion Criteria

contact lenses during the study
using eye drops
pregancy

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: efficiancy of Bimatoprost 03 mg/ml eyedrops on the lash-lenghtening;Secondary Objective: ther are no secondary objectives;Primary end point(s): no endpoints;Timepoint(s) of evaluation of this end point: no endpoints
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): no endpoints;Timepoint(s) of evaluation of this end point: no endpoints
© Copyright 2025. All Rights Reserved by MedPath